# Cluster4-9 Analysis

## Proteins: 

ADRM1, MIDN, PAAF1, PSMA1, PSMA4, PSMA5, PSMA6, PSMB10, PSMB7, PSMB8, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD12, PSMD13, PSMD14, PSMD3, PSMD4, PSMD5, PSMD8, PSMF1, TXNL1, USP14

Title: Human Cytosolic Proteasome System

Summary:

The human protein system under analysis consists of 25 proteins primarily located in the cytosol and involved in protein binding. The majority of these proteins (24) are part of the proteasome complex, which plays a crucial role in the degradation of ubiquitinated proteins through proteasome-mediated ubiquitin-dependent protein catabolic processes. The system also includes proteins associated with the proteasome accessory complex, proteasome core complex, and proteasome regulatory particle. The presence of deubiquitinase activity and endopeptidase activity further supports the system's involvement in protein degradation. Based on the cellular location and function, we propose the name "Human Cytosolic Proteasome System" for this protein system.

The Human Cytosolic Proteasome System is involved in various cellular processes, including protein degradation, ubiquitin-dependent protein catabolic processes, and proteasomal protein catabolic processes. The system also participates in the regulation of transcription by RNA polymerase II and NF-kappaB transcription factor activity. Additionally, some proteins within the system are associated with RNA binding, ATP binding, and ATP hydrolysis activity, which may contribute to the system's overall function.

Given the extensive involvement of these proteins in the proteasome complex and related processes, it is likely that this system represents a known complex rather than a novel one. However, further investigation is required to determine if any proteins within the system are novel members of a known complex.

References:

1. Collins, G. A., & Goldberg, A. L. (2017). The Logic of the 26S Proteasome. Cell, 169(5), 792-806. doi:10.1016/j.cell.2017.04.023
2. Finley, D. (2009). Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annual Review of Biochemistry, 78, 477-513. doi:10.1146/annurev.biochem.78.081507.101607
3. Tomko, R. J., & Hochstrasser, M. (2013). Molecular architecture and assembly of the eukaryotic proteasome. Annual Review of Biochemistry, 82, 415-445. doi:10.1146/annurev-biochem-060410-150257
4. Bard, J. A. M., Goodall, E. A., Greene, E. R., Jonsson, E., Dong, K. C., & Martin, A. (2018). Structure and Function of the 26S Proteasome. Annual Review of Biochemistry, 87, 697-724. doi:10.1146/annurev-biochem-062917-012724

### Validated References: 

[1] Pradhan, Ashis Kumar, Kandasamy, Ganapathi, Chatterjee, Upasana, Bharadwaj, Anushree, Mathew, Sam J, Dohmen, R JÃ¼rgen, Palanimurugan, R. "Ribosome-associated quality control mediates degradation of the premature translation termination product Orf1p of ODC antizyme mRNA." FEBS letters, 2021, pp. 2015-2033.

[2] Scott, Madeline R, Meador-Woodruff, James H. "Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects." Molecular psychiatry, 2020, pp. 776-790.



## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| cytosol | 25 | PSMD14, PSMA1, MIDN, ADRM1, PSMF1, PSMA4, PSMA5, PSMA6, PSMB10, PSMB7, PSMB8, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD12, PSMD13, PSMD3, PSMD4, PSMD5, PSMD8, TXNL1, USP14 |
| protein binding | 24 | PAAF1, PSMD14, PSMA1, MIDN, ADRM1, PSMF1, PSMA4, PSMA5, PSMA6, PSMB10, PSMB7, PSMB8, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD12, PSMD3, PSMD4, PSMD5, PSMD8, USP14 |
| proteasome complex | 24 | PAAF1, PSMD14, PSMA1, ADRM1, PSMA4, PSMA5, PSMA6, PSMB10, PSMB7, PSMB8, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD12, PSMD13, PSMD3, PSMD4, PSMD5, PSMD8, TXNL1, USP14 |
| nucleoplasm | 22 | PSMD14, PSMA1, ADRM1, PSMF1, PSMA4, PSMA5, PSMA6, PSMB10, PSMB7, PSMB8, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD12, PSMD13, PSMD3, PSMD4, PSMD5, PSMD8 |
| proteasome-mediated ubiquitin-dependent protein catabolic process | 20 | PSMD14, PSMA1, ADRM1, PSMF1, PSMA4, PSMA5, PSMA6, PSMB7, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD12, PSMD13, PSMD3, PSMD4, PSMD8, USP14 |
| nucleus | 20 | PSMD14, PSMA1, MIDN, PSMA4, PSMA5, PSMA6, PSMB10, PSMB7, PSMB8, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD13, PSMD3, PSMD4, PSMD8, TXNL1 |
| proteasome accessory complex | 13 | PSMD14, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD12, PSMD13, PSMD3, PSMD4, PSMD5, PSMD8 |
| cytoplasm | 10 | PSMA1, MIDN, PSMA4, PSMA5, PSMA6, PSMB7, PSMC2, PSMC5, PSMD12, TXNL1 |
| extracellular exosome | 10 | PSMA1, PSMA4, PSMA5, PSMA6, PSMB8, PSMC5, PSMC6, PSMD12, PSMD3, USP14 |
| membrane | 10 | PSMF1, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD12, PSMD13, PSMD3 |
|  proteasomal protein catabolic process | 8 | PSMD14, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, USP14 |
| extracellular region | 8 | PSMD14, PSMA5, PSMB7, PSMC2, PSMC3, PSMD12, PSMD13, PSMD3 |
| secretory granule lumen | 8 | PSMD14, PSMA5, PSMB7, PSMC2, PSMC3, PSMD12, PSMD13, PSMD3 |
| ficolin-1-rich granule lumen | 8 | PSMD14, PSMA5, PSMB7, PSMC2, PSMC3, PSMD12, PSMD13, PSMD3 |
| proteasome core complex | 8 | PSMA1, PSMF1, PSMA4, PSMA5, PSMA6, PSMB10, PSMB7, PSMB8 |
| proteasome regulatory particle, base subcomplex | 7 | PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD4 |
| proteasome regulatory particle, lid subcomplex | 6 | PSMD14, ADRM1, PSMD12, PSMD13, PSMD3, PSMD8 |
| ATP binding | 6 | PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6 |
| ATP hydrolysis activity | 6 | PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6 |
| proteasome-activating activity | 6 | PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6 |
| ubiquitin-dependent protein catabolic process | 5 | PSMD14, PSMF1, PSMC2, PSMD13, PSMD3 |
| proteasome binding | 4 | PSMD14, ADRM1, PSMF1, USP14 |
| RNA binding | 4 | PSMA1, PSMA6, PSMC1, PSMD4 |
| proteasome core complex, alpha-subunit complex | 4 | PSMA1, PSMA4, PSMA5, PSMA6 |
| P-body | 4 | PSMA4, PSMA6, PSMC2, PSMC3 |
| endopeptidase activity | 4 | PSMA6, PSMB10, PSMB7, PSMB8 |
| cytosolic proteasome complex | 3 | PSMD14, PSMC5, PSMC6 |
| proteolysis involved in protein catabolic process | 3 | PSMA6, PSMB10, PSMB8 |
| threonine-type endopeptidase activity | 3 | PSMB10, PSMB7, PSMB8 |
| proteasome core complex, beta-subunit complex | 3 | PSMB10, PSMB7, PSMB8 |
| identical protein binding | 3 | PSMC3, PSMC6, PSMD4 |
| proteasome regulatory particle | 3 | PSMD12, PSMD13, PSMD8 |
| endopeptidase activator activity | 2 | PSMD14, ADRM1 |
| K63-linked deubiquitinase activity | 2 | PSMD14, USP14 |
| protein deubiquitination | 2 | PSMD14, USP14 |
| polysome | 2 | PSMA1, PSMA6 |
| plasma membrane | 2 | ADRM1, USP14 |
| endopeptidase inhibitor activity | 2 | PSMF1, USP14 |
|  NF-kappaB transcription factor activity | 2 | PSMA6, USP14 |
| spermatoproteasome complex | 2 | PSMB10, PSMB8 |
| TBP-class protein binding | 2 | PSMC1, PSMC5 |
|  transcription by RNA polymerase II | 2 | PSMC3, PSMC5 |
|  inclusion body assembly | 2 | PSMC5, PSMC6 |
| inclusion body | 2 | PSMC5, PSMC6 |
| cytoplasmic vesicle | 2 | PSMC5, USP14 |

